Affimeds AFM28 Shows 40 percent Complete Remission Rate in Hard-to-Treat Leukemia Trial - StockTitan
| BIEL Stock | USD 0.0002 0.0001 33.33% |
About 60% of Bioelectronics Corp's investor base is looking to short. The analysis of overall sentiment of trading Bioelectronics Corp pink sheet suggests that many investors are alarmed at this time. Bioelectronics Corp's investing sentiment shows overall attitude of investors towards Bioelectronics Corp.
Bioelectronics Corp pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bioelectronics daily returns and investor perception about the current price of Bioelectronics Corp as well as its diversification or hedging effects on your existing portfolios.
Bioelectronics |
Affimeds AFM28 Shows 40 percent Complete Remission Rate in Hard-to-Treat Leukemia Trial StockTitan
Read at news.google.com
 |
Bioelectronics Corp Fundamental Analysis
We analyze Bioelectronics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioelectronics Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioelectronics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Bioelectronics Corp is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Peers
Trending Equities
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.